Medicare AdvantageCoverageMedium impact
MA06.024i, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Independence Blue Cross·Gastroenterology, Internal Medicine, Family Medicine·Medical Policy
Effective date
Jan 22, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.024i for noninvasive techniques in chronic liver disease evaluation and monitoring has been reissued with updates effective January 22, 2025. This policy change affects coverage criteria and billing requirements for noninvasive liver assessment procedures.
Action Required
Immediately: Review updated policy MA06.024i for changes to coverage criteria for noninvasive chronic liver disease evaluation procedures. Billing team should verify current prior authorization requirements and documentation standards for liver assessment services under Medicare Advantage plans.